Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OrthoPediatrics Corp. - Common Stock (NQ:KIDS)

21.55 -0.93 (-4.14%)
Streaming Delayed Price Updated: 12:01 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about OrthoPediatrics Corp. - Common Stock

< Previous 1 2 Next >
Demystifying OrthoPediatrics: Insights From 7 Analyst Reviews
Via Benzinga
Earnings Scheduled For May 7, 2025
Via Benzinga
Analyst Expectations For OrthoPediatrics's Future
Via Benzinga
Demystifying OrthoPediatrics: Insights From 4 Analyst Reviews
Via Benzinga
The Latest Analyst Ratings For OrthoPediatrics
Via Benzinga
The Latest Analyst Ratings For OrthoPediatrics
Via Benzinga
KIDS Stock Earnings: OrthoPediatrics Beats EPS, Beats Revenue for Q2 2024
KIDS stock results show that OrthoPediatrics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Expert Ratings For OrthoPediatrics
Via Benzinga
The Analyst Verdict: OrthoPediatrics In The Eyes Of 6 Experts
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For OrthoPediatrics
Via Benzinga
Earnings Scheduled For March 4, 2025
Via Benzinga
KIDS Stock Earnings: OrthoPediatrics Beats EPS, Beats Revenue for Q1 2024
KIDS stock results show that OrthoPediatrics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Recap: OrthoPediatrics Q4 Earnings
Via Benzinga
Earnings Outlook For OrthoPediatrics
Via Benzinga
Decoding 5 Analyst Evaluations For OrthoPediatrics
Via Benzinga
Analyst Ratings for OrthoPediatrics
Via Benzinga
American Eagle Reports Upbeat Earnings, Joins Kroger, Burlington Stores And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining more than 150 points on Thursday. 
Via Benzinga
Topics Stocks
KIDS Stock Earnings: OrthoPediatrics Beats EPS, Misses Revenue for Q4 2023
KIDS stock results show that OrthoPediatrics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Alphabet To Rally Over 10%? Here Are 10 Other Analyst Forecasts For Wednesday
Citigroup raised the price target for LyondellBasell Industries N.V. (NYSE: LYB) from $104 to $106. Citigroup analyst Patrick Cunningham upgraded the stock from Neutral to Buy. LyondellBasell... 
Via Benzinga
4 Analysts Have This to Say About OrthoPediatrics
Via Benzinga
OrthoPediatrics's Earnings: A Preview
Via Benzinga
Analyst Ratings for OrthoPediatrics
Via Benzinga
OrthoPediatrics's Earnings Outlook
Via Benzinga
Analyst Expectations for OrthoPediatrics's Future
Via Benzinga
Earnings Scheduled For March 6, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. 
Via Benzinga
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
Where OrthoPediatrics Stands With Analysts
OrthoPediatrics (NASDAQ:KIDS) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Earnings Scheduled For July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million. 
Via Benzinga
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
Respiratory Infections Led OrthoPediatrics Miss Quarterly Sales Expectations, Analyst Calls It Transitory Issue
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.